Historical snapshot from Q1 2024.View current holdings →
In Q1 2024, Deerfield Management held 233 positions worth $4.2B. They initiated 149 new positions and exited 105. Their largest holding was NUVL ($1.5B). Portfolio value shrank -1.1% versus the prior quarter.
Portfolio Value (13F)
$4.2B
Holdings
233
Top 10 Concentration
66.0%
QoQ Change
-1.1%
Turnover
7.7%
Sector Breakdown
Biotechnology92%(201)
Other Healthcare8%(32)
Q1 2024 Holdings (233)
| # | Ticker | Company | Change | Value | % of Portfolio | SI % Float ? |
|---|---|---|---|---|---|---|
| 1 | NUVL | Nuvalent Inc. | $1.5B | 35.41% | 6.2% | |
| 2 | VTRS | Viatris Inc. | Increased | $255.5M | 6.03% | 3.7% |
| 3 | LRMR | Larimar Therapeutics, Inc. | Increased | $161.2M | 3.80% | 22.9% |
| 4 | AHCO | AdaptHealth Corp. | Decreased | $152.6M | 3.60% | 9.6% |
| 5 | CPRX | Catalyst Pharmaceuticals Inc. | Increased | $145.5M | 3.43% | 8.3% |
| 6 | OSCR | Oscar Health, Inc. | Decreased | $139.4M | 3.29% | 6.5% |
| 7 | KURA | Kura Oncology, Inc. | Increased | $115.4M | 2.72% | 16.6% |
| 8 | IDYA | IDEAYA Biosciences Inc. | $115.4M | 2.72% | 11.1% | |
| 9 | SPRY | ARS Pharmaceuticals, Inc. | $113.2M | 2.67% | 30.7% | |
| 10 | RVMD | Revolution Medicines Inc. | $99.6M | 2.35% | 5.9% | |
| 11 | NBIX | Neurocrine Biosciences Inc. | Decreased | $95.3M | 2.25% | 7.5% |
| 12 | SGRYOther Healthcare | Surgery Partners, Inc. | Increased | $95.1M | 2.24% | 21.7% |
| 13 | DCPH | Deciphera Pharmaceuticals Inc. | Decreased | $80.7M | 1.90% | — |
| 14 | SWTX | SpringWorks Therapeutics Inc. | Decreased | $63.2M | 1.49% | — |
| 15 | EHABOther Healthcare | Enhabit, Inc. | $58.2M | 1.37% | 2.4% | |
| 16 | NKTX | Nkarta, Inc. | Increased | $56.1M | 1.32% | 6.4% |
| 17 | BNTX | BioNTech SE | New | $52.5M | 1.24% | 3.7% |
| 18 | EWTX | Edgewise Therapeutics, Inc. | Decreased | $52.4M | 1.24% | 14.6% |
| 19 | GLPGF | Galapagos NV | Increased | $45.4M | 1.07% | — |
| 20 | GPCR | Structure Therapeutics Inc. | Increased | $44.3M | 1.05% | 14.5% |
| 21 | IRON | Disc Medicine Inc. | Increased | $41.4M | 0.98% | 22.1% |
| 22 | ALHC | Alignment Healthcare, Inc. | Increased | $41.0M | 0.97% | 11.7% |
| 23 | VKTX | Viking Therapeutics Inc. | Decreased | $38.0M | 0.90% | 21.4% |
| 24 | KYTX | Kyverna Therapeutics, Inc. | New | $36.3M | 0.86% | 18.3% |
| 25 | EMBCOther Healthcare | Embecta Corp. | Increased | $36.2M | 0.85% | 12.4% |
| 26 | SLDB | Solid Biosciences Inc. | New | $30.1M | 0.71% | 13.5% |
| 27 | DAWN | Day One Biopharmaceuticals Inc. | Held | $29.2M | 0.69% | 7.5% |
| 28 | CNMDOther Healthcare | Conmed Corp. | Increased | $27.1M | 0.64% | 7.8% |
| 29 | BCRX | Biocryst Pharmaceuticals Inc. | Increased | $25.4M | 0.60% | 10.8% |
| 30 | INMDOther Healthcare | InMode Ltd. | New | $25.2M | 0.59% | 4.4% |
| 31 | ACCDOther Healthcare | Accolade Inc. | Decreased | $25.0M | 0.59% | — |
| 32 | PHVS | Pharvaris N.V. | Increased | $24.5M | 0.58% | 3.5% |
| 33 | AUTL | Autolus Therapeutics plc | New | $23.2M | 0.55% | 4.9% |
| 34 | APGE | Apogee Therapeutics Inc. | New | $21.9M | 0.52% | 7.3% |
| 35 | CABA | Cabaletta Bio, Inc. | Decreased | $21.5M | 0.51% | 25.1% |
| 36 | DCGOOther Healthcare | DocGo Inc. | Decreased | $20.6M | 0.49% | 2.1% |
| 37 | CSTL | Castle Biosciences Inc. | Decreased | $20.6M | 0.48% | 6.7% |
| 38 | PRLD | Prelude Therapeutics Inc. | $19.6M | 0.46% | 18.1% | |
| 39 | CGEM | Cullinan Therapeutics, Inc. | New | $19.4M | 0.46% | 16.5% |
| 40 | PODDOther Healthcare | Insulet Corp. | Decreased | $18.9M | 0.44% | 8.7% |
| 41 | VSTM | Verastem, Inc. | $18.2M | 0.43% | 16.6% | |
| 42 | NAMSW | NewAmsterdam Pharma Co N.V. | Increased | $16.8M | 0.40% | — |
| 43 | GH | Guardant Health Inc. | $16.3M | 0.39% | 9.3% | |
| 44 | FATE | Fate Therapeutics Inc. | New | $16.1M | 0.38% | 10.1% |
| 45 | LNTH | Lantheus Holdings Inc. | New | $14.9M | 0.35% | 6.8% |
| 46 | ENGNW | enGene Holdings Inc. | New | $13.6M | 0.32% | — |
| 47 | TNGX | Tango Therapeutics Inc. | $12.2M | 0.29% | 26.7% | |
| 48 | EYPT | EyePoint, Inc. | New | $12.0M | 0.28% | 25.4% |
| 49 | COGT | Cogent Biosciences Inc. | Increased | $10.3M | 0.24% | 11.3% |
| 50 | ITOS | iTeos Therapeutics SA | $9.9M | 0.23% | — | |
| 51 | REPL | Replimune Group Inc. | Decreased | $6.6M | 0.15% | 34.2% |
| 52 | ALEC | Alector Inc. | Held | $6.5M | 0.15% | 5.8% |
| 53 | PRME | Prime Medicine, Inc. | $6.2M | 0.15% | 22.6% | |
| 54 | GUTS | Fractyl Health, Inc. | New | $6.2M | 0.15% | 1.4% |
| 55 | WGSWWOther Healthcare | GeneDx Holdings Corp. | $5.9M | 0.14% | — | |
| 56 | TOIIWOther Healthcare | Oncology Institute, Inc. | $5.6M | 0.13% | — | |
| 57 | ANNX | Annexon Biosciences Inc. | $4.2M | 0.10% | 17.9% | |
| 58 | CALC | CalciMedica, Inc. | Increased | $4.2M | 0.10% | 2.3% |
| 59 | PHGE | BiomX Inc. | New | $2.8M | 0.06% | 2.3% |
| 60 | CGON | CG Oncology, Inc. | New | $2.1M | 0.05% | 12.0% |
| 61 | DXC | DXC Technology Co | New | $1.3M | 0.03% | 19.0% |
| 62 | DRI | Darden Restaurants Inc. | New | $1.1M | 0.02% | 8.0% |
| 63 | EA | Electronic Arts Inc. | New | $876K | 0.02% | 4.0% |
| 64 | APG | APi Group Corp. | New | $874K | 0.02% | 2.7% |
| 65 | NVDA | Nvidia Corp. | Decreased | $857K | 0.02% | 1.3% |
| 66 | SNX | TD Synnex Corp. | New | $813K | 0.02% | 2.6% |
| 67 | PII | Polaris Inc. | New | $797K | 0.02% | 14.1% |
| 68 | MNKD | MannKind Corporation | New | $758K | 0.02% | 8.2% |
| 69 | SKYT | SkyWater Technology, Inc. | New | $728K | 0.02% | 7.3% |
| 70 | ZTS | Zoetis Inc. | New | $709K | 0.02% | 5.0% |
| 71 | DRS | Leonardo DRS, Inc. | New | $704K | 0.02% | 1.2% |
| 72 | FCN | Fti Consulting, Inc. | New | $682K | 0.02% | 18.7% |
| 73 | AGYS | Agilysys Inc. | New | $674K | 0.02% | 7.4% |
| 74 | ACLS | Axcelis Technologies Inc. | New | $666K | 0.02% | 6.7% |
| 75 | ATRCOther Healthcare | AtriCure, Inc. | New | $631K | 0.01% | 9.9% |
| 76 | FTNT | Fortinet, Inc. | New | $616K | 0.01% | 2.1% |
| 77 | GTLS | Chart Industries Inc. | New | $613K | 0.01% | 10.9% |
| 78 | V | Visa Inc. | New | $596K | 0.01% | 1.2% |
| 79 | VRSK | Verisk Analytics, Inc. | New | $593K | 0.01% | 3.7% |
| 80 | AAPL | Apple Inc. | New | $591K | 0.01% | 0.8% |
| 81 | FLS | Flowserve Corp. | New | $587K | 0.01% | 7.2% |
| 82 | SWKS | Skyworks Solutions, Inc. | New | $586K | 0.01% | 29.3% |
| 83 | IMNM | Immunome Inc. | New | $568K | 0.01% | 17.3% |
| 84 | GCO | Genesco Inc. | New | $557K | 0.01% | 12.8% |
| 85 | APTV | Aptiv PLC | New | $556K | 0.01% | 6.1% |
| 86 | AXP | American Express CO | Increased | $538K | 0.01% | 2.1% |
| 87 | ADMA | ADMA Biologics Inc. | Increased | $536K | 0.01% | 11.3% |
| 88 | BBY | Best Buy CO Inc. | New | $530K | 0.01% | 8.0% |
| 89 | CHWY | Chewy, Inc. | New | $525K | 0.01% | 13.7% |
| 90 | ADBE | Adobe Inc. | New | $517K | 0.01% | 5.1% |
| 91 | AGIO | Agios Pharmaceuticals Inc. | New | $516K | 0.01% | 11.9% |
| 92 | UTI | Universal Technical Institute Inc. | Decreased | $494K | 0.01% | 13.9% |
| 93 | ULTA | Ulta Beauty, Inc. | New | $492K | 0.01% | 5.7% |
| 94 | IR | Ingersoll Rand Inc. | New | $481K | 0.01% | 4.0% |
| 95 | BBDC | Barings BDC, Inc. | New | $463K | 0.01% | 2.8% |
| 96 | FSLY | Fastly, Inc. | New | $461K | 0.01% | 15.5% |
| 97 | AZZ | Azz Inc. | New | $459K | 0.01% | 3.2% |
| 98 | MPLXP | Mplx LP | New | $453K | 0.01% | — |
| 99 | LMATOther Healthcare | Lemaitre Vascular Inc. | New | $449K | 0.01% | 9.6% |
| 100 | HALO | Halozyme Therapeutics Inc. | New | $449K | 0.01% | 17.7% |
| 101 | MU | Micron Technology Inc. | New | $448K | 0.01% | 2.3% |
| 102 | HNST | Honest Company, Inc. | New | $441K | 0.01% | 10.3% |
| 103 | VERA | Vera Therapeutics Inc. | Increased | $440K | 0.01% | 27.2% |
| 104 | ALTG-PA | Alta Equipment Group Inc. | New | $438K | 0.01% | — |
| 105 | W | Wayfair Inc. | New | $427K | 0.01% | 13.8% |
| 106 | RXSTOther Healthcare | RxSight Inc. | New | $422K | 0.01% | 10.4% |
| 107 | RVTYOther Healthcare | Revvity, Inc. | New | $421K | 0.01% | 8.5% |
| 108 | XNCR | Xencor Inc. | New | $420K | 0.01% | 31.2% |
| 109 | AGLOther Healthcare | agilon health, Inc. | New | $415K | 0.01% | 9.6% |
| 110 | BA-PA | Boeing CO | New | $407K | 0.01% | — |
| 111 | FIVE | Five Below, Inc. | New | $405K | 0.01% | 5.3% |
| 112 | CYTK | Cytokinetics Incorporated | Increased | $404K | 0.01% | 21.2% |
| 113 | ESAB | Esab Corp. | New | $392K | 0.01% | 10.3% |
| 114 | GL-PD | Globe Life Inc. | New | $391K | 0.01% | — |
| 115 | HURN | Huron Consulting Group Inc. | Increased | $388K | 0.01% | 5.3% |
| 116 | HCIIP | HCI Group, Inc. | Decreased | $387K | 0.01% | — |
| 117 | DD | DuPont de Nemours, Inc. | New | $385K | 0.01% | 4.3% |
| 118 | INCY | Incyte Corporation | Increased | $380K | 0.01% | 8.4% |
| 119 | HQYOther Healthcare | Healthequity, Inc. | New | $380K | 0.01% | 9.6% |
| 120 | DRUG | Bright Minds Biosciences Inc. | New | $378K | 0.01% | 11.6% |
| 121 | KELYA | Kelly Services Inc. | New | $377K | 0.01% | 3.6% |
| 122 | BRBR | Bellring Brands, Inc. | New | $374K | 0.01% | 12.1% |
| 123 | J | Jacobs Solutions Inc. | New | $372K | 0.01% | 3.9% |
| 124 | ORCL-PD | Oracle Corp. | New | $371K | 0.01% | — |
| 125 | DLX | Deluxe Corp. | New | $368K | 0.01% | 11.7% |
| 126 | USNA | Usana Health Sciences Inc. | New | $363K | 0.01% | 7.1% |
| 127 | NHC | National Healthcare Corp. | New | $356K | 0.01% | 6.4% |
| 128 | PLTR | Palantir Technologies Inc. | New | $353K | 0.01% | 2.6% |
| 129 | DE | Deere & CO | New | $353K | 0.01% | 2.1% |
| 130 | LTH | Life Time Group Holdings, Inc. | Increased | $349K | 0.01% | 8.3% |
| 131 | COLD | Americold Realty Trust | New | $349K | 0.01% | 10.2% |
| 132 | PRA | Proassurance Corp. | New | $345K | 0.01% | 24.1% |
| 133 | AKRO | Akero Therapeutics Inc. | New | $345K | 0.01% | — |
| 134 | NYT | New York Times CO | New | $344K | 0.01% | 11.7% |
| 135 | COLM | Columbia Sportswear CO | New | $342K | 0.01% | 17.5% |
| 136 | T-PC | At&T Inc. | New | $342K | 0.01% | — |
| 137 | WMT | Walmart Inc. | New | $339K | 0.01% | 1.8% |
| 138 | TTI | Tetra Technologies Inc. | New | $338K | 0.01% | 8.0% |
| 139 | AMCX | AMC Networks Inc. | New | $338K | 0.01% | 19.5% |
| 140 | PEP | Pepsico Inc. | New | $334K | 0.01% | 1.9% |
| 141 | ARQT | Arcus Biosciences Inc. | New | $334K | 0.01% | 18.4% |
| 142 | LFMDPOther Healthcare | LifeMD, Inc. | New | $330K | 0.01% | — |
| 143 | SD | Sandridge Energy Inc. | New | $329K | 0.01% | 5.4% |
| 144 | MRCY | Mercury Systems Inc. | New | $323K | 0.01% | 9.5% |
| 145 | THRM | Gentherm Inc. | New | $320K | 0.01% | 8.4% |
| 146 | ANIP | Ani Pharmaceuticals Inc. | Decreased | $320K | 0.01% | 18.5% |
| 147 | CRI | Carters Inc. | New | $317K | 0.01% | 25.0% |
| 148 | RDNTOther Healthcare | RadNet, Inc. | New | $314K | 0.01% | 14.1% |
| 149 | SONO | Sonos Inc. | New | $313K | 0.01% | 20.3% |
| 150 | CASH | Pathward Financial, Inc. | New | $312K | 0.01% | 16.7% |
| 151 | COLL | Collegium Pharmaceutical, Inc. | Decreased | $311K | 0.01% | 20.2% |
| 152 | ARES-PB | Ares Management Corp. | New | $306K | 0.01% | — |
| 153 | ALGNOther Healthcare | Align Technology Inc. | New | $300K | 0.01% | 6.8% |
| 154 | VYGR | Voyager Therapeutics Inc. | Increased | $298K | 0.01% | 7.5% |
| 155 | ED | Consolidated Edison Inc. | New | $297K | 0.01% | 4.0% |
| 156 | GPI | Group 1 Automotive Inc. | New | $294K | 0.01% | 17.6% |
| 157 | CVGW | Calavo Growers Inc. | New | $294K | 0.01% | 5.9% |
| 158 | FRSH | Freshworks Inc. | New | $292K | 0.01% | 10.9% |
| 159 | CTVA | Corteva, Inc. | New | $292K | 0.01% | 3.7% |
| 160 | OCUL | Ocular Therapeutix Inc. | Increased | $290K | 0.01% | 15.8% |
| 161 | TIPT | Tiptree Inc. | New | $289K | 0.01% | 3.4% |
| 162 | TRV | Travelers Companies, Inc. | New | $288K | 0.01% | 3.2% |
| 163 | DGXOther Healthcare | Quest Diagnostics Inc. | New | $287K | 0.01% | 3.1% |
| 164 | HRMY | Harmony Biosciences Holdings Inc. | New | $283K | 0.01% | 12.7% |
| 165 | AMSF | Amerisafe Inc. | New | $283K | 0.01% | 3.2% |
| 166 | FDMT | 4D Molecular Therapeutics, Inc. | Increased | $281K | 0.01% | 23.3% |
| 167 | CFLT | Confluent, Inc. | New | $274K | 0.01% | 9.1% |
| 168 | VEEV | Veeva Systems Inc. | New | $272K | 0.01% | 3.3% |
| 169 | LQDA | Liquidia Corporation | New | $272K | 0.01% | 17.5% |
| 170 | WRB-PH | Berkley W R Corp. | New | $269K | 0.01% | — |
| 171 | WRB-PG | Berkley W R Corp. | New | $269K | 0.01% | — |
| 172 | ABSI | Absci Corp. | New | $269K | 0.01% | 26.6% |
| 173 | MRVL | Marvell Technology, Inc. | Decreased | $261K | 0.01% | 3.2% |
| 174 | TRIBOther Healthcare | Trinity Biotech Plc | Decreased | $260K | 0.01% | 5.6% |
| 175 | ECVT | Ecovyst Inc. | New | $259K | 0.01% | 5.5% |
| 176 | MRSN | Mersana Therapeutics Inc. | Increased | $258K | 0.01% | — |
| 177 | MS-PL | Morgan Stanley | New | $257K | 0.01% | — |
| 178 | PGNYOther Healthcare | Progyny Inc. | New | $256K | 0.01% | 9.4% |
| 179 | ECL | Ecolab Inc. | Decreased | $256K | 0.01% | 2.2% |
| 180 | XRAYOther Healthcare | Dentsply Sirona Inc. | New | $255K | 0.01% | 14.3% |
| 181 | CAHOther Healthcare | Cardinal Health Inc. | New | $255K | 0.01% | 3.7% |
| 182 | MRNA | Moderna Inc. | New | $249K | 0.01% | 9.4% |
| 183 | VC | Visteon Corp. | Decreased | $248K | 0.01% | 18.0% |
| 184 | GOOG | Alphabet Inc. | New | $248K | 0.01% | — |
| 185 | NGL-PC | NGL Energy Partners LP | New | $247K | 0.01% | — |
| 186 | NRIX | Nurix Therapeutics Inc. | Increased | $243K | 0.01% | 16.3% |
| 187 | UNHOther Healthcare | Unitedhealth Group Inc. | New | $242K | 0.01% | 2.0% |
| 188 | FLGT | Fulgent Genetics Inc. | Increased | $238K | 0.01% | 13.1% |
| 189 | CCCC | C4 Therapeutics Inc. | New | $234K | 0.01% | 33.0% |
| 190 | RITM-PD | Rithm Capital Corp. | New | $232K | 0.01% | — |
| 191 | FAST | Fastenal CO | New | $229K | 0.01% | 3.4% |
| 192 | EXPO | Exponent Inc. | New | $229K | 0.01% | 7.6% |
| 193 | CUBB | Customers Bancorp, Inc. | Held | $228K | 0.01% | — |
| 194 | SUPN | Supernus Pharmaceuticals, Inc. | Decreased | $227K | 0.01% | 10.5% |
| 195 | WWD | Woodward, Inc. | Decreased | $225K | 0.01% | 2.1% |
| 196 | DYN | Dyne Therapeutics Inc. | New | $225K | 0.01% | 17.8% |
| 197 | VCYT | Veracyte, Inc. | New | $222K | 0.01% | 15.0% |
| 198 | HCC | Warrior Met Coal, Inc. | New | $219K | 0.01% | 10.6% |
| 199 | MET-PF | Metlife Inc. | New | $218K | 0.01% | — |
| 200 | HROW | Harrow, Inc. | New | $216K | 0.01% | 23.0% |
| 201 | LABOther Healthcare | Standard Biotools Inc. | Increased | $212K | 0.01% | 1.1% |
| 202 | S | SentinelOne, Inc. | New | $210K | 0.00% | 5.6% |
| 203 | KMX | Carmax Inc. | New | $210K | 0.00% | 8.6% |
| 204 | ADPT | Adaptive Biotechnologies Corporation | New | $210K | 0.00% | 9.4% |
| 205 | SLRC | SLR Investment Corp. | New | $209K | 0.00% | 2.3% |
| 206 | XRXDW | Xerox Holdings Corp. | New | $208K | 0.00% | — |
| 207 | EXEL | Exelixis Inc. | Increased | $208K | 0.00% | 15.6% |
| 208 | MSI | Motorola Solutions, Inc. | Decreased | $206K | 0.00% | 2.3% |
| 209 | MMS | Maximus, Inc. | Decreased | $206K | 0.00% | 11.6% |
| 210 | KDP | Keurig Dr Pepper Inc. | New | $200K | 0.00% | 6.0% |
| 211 | HAIN | Hain Celestial Group Inc. | New | $199K | 0.00% | 5.5% |
| 212 | FOLD | Amicus Therapeutics Inc. | New | $194K | 0.00% | 7.0% |
| 213 | RUN | Sunrun Inc. | New | $189K | 0.00% | 35.2% |
| 214 | LUNGOther Healthcare | Pulmonx Corporation | Increased | $188K | 0.00% | 2.2% |
| 215 | KALV | KalVista Pharmaceuticals, Inc. | New | $182K | 0.00% | 14.4% |
| 216 | INOD | Innodata Inc. | New | $180K | 0.00% | 14.1% |
| 217 | XERS | Xeris Biopharma Holdings, Inc. | Increased | $163K | 0.00% | 4.1% |
| 218 | HIMSOther Healthcare | Hims & Hers Health, Inc. | Decreased | $163K | 0.00% | 28.2% |
| 219 | PAHC | Phibro Animal Health Corp. | New | $161K | 0.00% | 5.8% |
| 220 | MBI | Mbia Inc. | New | $161K | 0.00% | 6.4% |
| 221 | TERN | Terns Pharmaceuticals Inc. | Increased | $158K | 0.00% | 7.0% |
| 222 | VERV | Verve Therapeutics Inc. | New | $153K | 0.00% | — |
| 223 | ATECOther Healthcare | Alphatec Holdings, Inc. | Increased | $140K | 0.00% | 10.5% |
| 224 | WEAV | Weave Communications, Inc. | Increased | $138K | 0.00% | 7.5% |
| 225 | CERSOther Healthcare | Cerus Corporation | New | $113K | 0.00% | 9.0% |
| 226 | SABR | Sabre Corp. | New | $111K | 0.00% | 9.6% |
| 227 | HCATOther Healthcare | Health Catalyst, Inc. | Increased | $111K | 0.00% | 3.6% |
| 228 | STRO | Sutro Biopharma, Inc. | New | $96K | 0.00% | 11.2% |
| 229 | AKBA | Akebia Therapeutics, Inc. | New | $86K | 0.00% | 8.2% |
| 230 | PAYO | Payoneer Global Inc. | New | $78K | 0.00% | 5.5% |
| 231 | NUVB | Nuvation Bio Inc. | $50K | 0.00% | 27.6% | |
| 232 | DNABW | Ginkgo Bioworks Holdings, Inc. | New | $41K | 0.00% | — |
| 233 | BFLYOther Healthcare | Butterfly Network, Inc. | $33K | 0.00% | 14.8% |
Top Movers This Quarter
Share changes reflect active decisions. Value changes include price moves.
Frequently asked questions
What stocks did Deerfield Management own in Q1 2024?
Deerfield Management held 233 biotech stocks in their 13F portfolio in Q1 2024. Their top positions include NUVL, VTRS, LRMR, AHCO, CPRX. The full holdings table is available on BiotechEdge with position sizes, quarter-over-quarter changes, and AI analysis.
How much was Deerfield Management's portfolio worth in Q1 2024?
Deerfield Management's tracked biotech portfolio was worth $4.2B across 233 positions, with total assets under management of approximately $16B. Portfolio values are based on 13F filings with the SEC.
What did Deerfield Management buy in Q1 2024?
Deerfield Management initiated 149 new positions in Q1 2024, including BNTX, KYTX, SLDB, INMD, AUTL and 144 more. They also increased 40 existing positions.
What did Deerfield Management sell in Q1 2024?
Deerfield Management fully exited 105 positions in Q1 2024, including PCRX, PACB, MIRM, KRYS, IOVA and 100 more. They also trimmed 28 existing positions.
Is Deerfield Management a biotech fund?
Multi-strategy healthcare fund with one of the longest track records in the space. Deerfield invests across public equity, private equity, structured credit, and royalties in healthcare. Known for creative financing structures and deep industry relationships across pharma and biotech.
Want AI analysis, insider signals, and catalyst overlays for Deerfield Management?
View latest Deerfield Management portfolio →